SpineZone
Company

Last deal

$15M

Amount

Series B

Stage

02.05.2024

Date

2

all rounds

$27M

Total amount

General

About Company
SpineZone provides non-operative, personalized treatment for musculoskeletal conditions.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company offers a data-driven back pain program that assesses patients and customizes a 6-week treatment plan with a coach to help them progress. SpineZone's program aims to reduce the need for surgery, prescription drugs, or injections, and has helped thousands of chronic back pain patients with lower rates of surgery, injection, and cost. The system eliminates patient overtreatment with a multi-disciplinary team of caregivers under one roof and software to track the patient's recovery. Four large health institutions have used SpineZone and realized a 70% cost savings compared to traditional back pain programs, 46% reduction in patient pain levels, and a 5x improvement in patient compliance. Developed by orthopedic surgeons, SpineZone is a complete, vertically-integrated system that medical groups use to reduce the cost of their back pain population while improving patient satisfaction.
Contacts

Phone number

Social url